Dr. Shyam Rathi – Haematologist and Bone Marrow Transplant Specialist in Navi Mumbai
Dr. Shyam Rathi is a Consultant Haematologist and Haemato-Oncologist associated with Hiranandani Fortis Hospital, Vashi, Navi Mumbai. His clinical expertise includes the diagnosis and treatment of blood disorders, haematological cancers and conditions requiring stem cell transplantation. His professional interests focus on leukaemia, multiple myeloma and bone marrow transplant care.
Dr. Rathi completed his MBBS in 2002, followed by an MD in General Medicine from K. J. Somaiya Medical College and Research Centre, Mumbai, in 2006. He subsequently completed his DM in Clinical Haematology at the All India Institute of Medical Sciences, New Delhi, in 2010. His additional fellowship training includes leukaemia and bone marrow transplantation.
His areas of clinical expertise include leukaemia, lymphoma, multiple myeloma and other haematological malignancies. These disorders affect blood cells, bone marrow or lymphatic tissues and may require specialized investigations to establish the diagnosis and determine the appropriate treatment approach.
Dr. Rathi has documented expertise in bone marrow and stem cell transplantation. These treatments may be considered for selected blood cancers and other haematological conditions. Transplant planning requires detailed assessment of disease status, donor suitability, organ function and the patient's overall medical condition.
His professional background includes experience in haematological malignancy management and intensive treatment requiring careful monitoring. He is associated with the American Society of Hematology and Indian Society of Hematology. His hospital profile also reports several professional awards and recognitions.
Patients seeking a haematologist or bone marrow transplant specialist in Navi Mumbai can consult Dr. Shyam Rathi for assessment of blood disorders, leukaemia, lymphoma, multiple myeloma and transplant-related concerns. His approach emphasizes appropriate diagnosis, treatment selection and ongoing monitoring.